Astra Microwave Products Fund Raise of ₹174 Cr

Astra Microwave Products Board Meeting Date

Astra Microwave scheduled its Board meeting for November 12, 2026 to approve Q2 and H1 FY27 results. No financial figures or decisions are reported in this advance intimation.

Astra Microwave Products Merger & Restructuring

Astra Microwave received exchange observation letters for its Space business demerger into Astra Space Technologies. The scheme remains subject to regulatory approvals.

Astra Microwave Products Other Announcement

Astra Microwave Products Ltd filed its quarterly shareholding pattern as of September 30, 2026, detailing the distribution of equity across promoter and public shareholder categories.

Astra Microwave Products Annual General Meeting

Astra Microwave Products Limited conducted its 35th Annual General Meeting on September 18, 2026, where shareholders discussed agenda items, including financial statements and director appointments.

Astra Microwave Products Credit Rating

Astra Microwave Products Limited received an upgraded credit rating of 'CRISIL A+/Stable' for its long-term bank facilities and corporate credit rating from CRISIL Ratings Limited.

Astra Microwave Products Promoter Selling: ₹66.08 Cr

Director Atim Kabra sold 3,91,700 equity shares of Astra Microwave Products Ltd via market sale. The transaction was valued at approximately ₹66.08 Crore.

Value

₹66.08 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.